Arkolith/Insider Trading/DTIL/Form 4

Kelly John Alexander

Chief Financial OfficerPRECISION BIOSCIENCES INC (DTIL) · full profile →Form 4 · filed Jan 22, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$61K
Net Open-Market Flow
-$61K
Transactions
7
4 non-derivative · 3 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jan 21, 2026Sell(S)15K$4.03$61K106K
Jan 20, 2026Option exercise(M)27K——122K
Jan 20, 2026Option exercise(M)4K——81K
Jan 20, 2026Option exercise(M)14K——95K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jan 20, 2026Option exercise(M)27K—$027K
Jan 20, 2026Option exercise(M)14K—$014K
Jan 20, 2026Option exercise(M)4K—$00

Transaction Codes

S
Open-market sale
M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001628280-26-003147) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML